These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2785086)
1. Effect of long-term treatment with platelet-activating factor on cytokine production by rat spleen cells. Pignol B; Hénane S; Mencia-Huerta JM; Braquet P Int Arch Allergy Appl Immunol; 1989; 88(1-2):161-3. PubMed ID: 2785086 [TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells. Pignol B; Hénane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865 [TBL] [Abstract][Full Text] [Related]
3. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes. Pignol B; Hénane S; Mencia-Huerta JM; Rola-Pleszczynski M; Braquet P Prostaglandins; 1987 Jun; 33(6):931-9. PubMed ID: 3313526 [TBL] [Abstract][Full Text] [Related]
4. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat. Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. Rola-Pleszczynski M; Pignol B; Pouliot C; Braquet P Biochem Biophys Res Commun; 1987 Feb; 142(3):754-60. PubMed ID: 3493773 [TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. Thivierge M; Rola-Pleszczynski M J Allergy Clin Immunol; 1992 Nov; 90(5):796-802. PubMed ID: 1331218 [TBL] [Abstract][Full Text] [Related]
8. Effects of intrastriatal injections of platelet-activating factor and the PAF antagonist BN 52021 on memory. Packard MG; Teather LA; Bazan NG Neurobiol Learn Mem; 1996 Sep; 66(2):176-82. PubMed ID: 8946410 [TBL] [Abstract][Full Text] [Related]
9. Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig. Touvay C; Pfister A; Vilain B; Carré C; Page CP; Lellouch-Tubiana A; Pignol B; Mencia-Huerta JM; Braquet P Pulm Pharmacol; 1991; 4(1):43-51. PubMed ID: 1804494 [TBL] [Abstract][Full Text] [Related]
10. [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro]. Poveshchenko AF; Kozlov VA Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):53-6. PubMed ID: 10852052 [TBL] [Abstract][Full Text] [Related]
11. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021. Jancar S; Braquet P; Sirois P Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218 [TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286 [TBL] [Abstract][Full Text] [Related]
13. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Sirois MG; Plante GE; Braquet P; Sirois P Br J Pharmacol; 1990 Dec; 101(4):896-900. PubMed ID: 2085713 [TBL] [Abstract][Full Text] [Related]
14. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. Sirois MG; Jancar S; Braquet P; Plante GE; Sirois P Prostaglandins; 1988 Nov; 36(5):631-44. PubMed ID: 3238010 [TBL] [Abstract][Full Text] [Related]
15. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577 [TBL] [Abstract][Full Text] [Related]
16. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Sneddon AA; McLeod E; Wahle KW; Arthur JR Biochim Biophys Acta; 2006 Jul; 1761(7):793-801. PubMed ID: 16829183 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. Gozal D; Holt GA; Graff GR; Torres JE Am J Physiol; 1998 Aug; 275(2):R604-11. PubMed ID: 9688699 [TBL] [Abstract][Full Text] [Related]
18. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659 [TBL] [Abstract][Full Text] [Related]
19. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats. Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149 [TBL] [Abstract][Full Text] [Related]
20. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. Pignol B; Henane S; Pirotzky E; Mencia-Huerta JM; Braquet P Transplant Proc; 1988 Apr; 20(2 Suppl 2):259-65. PubMed ID: 3259039 [No Abstract] [Full Text] [Related] [Next] [New Search]